推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CELLULAR ONCOLOGY 期刊收藏夹

2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
聚合物期刊JPM征稿|IF持续上升 + APC折扣
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CELLULAR ONCOLOGY期刊基本信息Hello,您是该期刊的第55133位访客


基本信息 登录收藏
期刊名字CELLULAR ONCOLOGYCELLULAR ONCOLOGY


(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.8
58人评分
我要评分

声誉
7.9

影响力
5.8

速度
7.3

期刊ISSN1570-5870
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
P-ISSN2211-3428
E-ISSN2211-3436
2024-2025最新影响因子
(数据来源于搜索引擎)
4.8 点击查看影响因子趋势图
实时影响因子 截止2026年5月06日:5.59
2024-2025自引率0.0%点击查看自引率趋势图
五年影响因子5.4
JCI期刊引文指标 1.18
h-index 暂无h-index数据
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
8.601.5611.004
学科分区排名百分位
大类:Medicine
小类:Oncology
Q170 / 428
大类:Medicine
小类:Molecular Medicine
Q143 / 179
大类:Medicine
小类:Cancer Research
Q260 / 233

期刊简介
The Official Journal of the International Society for Cellular Oncology
Focuses on translational research
Addresses the conversion of cell biology to clinical applications
Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.
In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.
期刊官方网站https://www.springer.com/13402
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/ceon
作者指南网址https://www.springer.com/13402/submission-guidelines
该期刊中国学者近期发文 - NewEBF3 suppresses lung adenocarcinoma progression and immune evasion via transcriptional repression of CCL24
Author: Li, Lan; Yang, YiRan; Li, Dan; Chen, ChuMao; Mu, XinMei; Wu, JiaXin; Yuan, Jin
Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 3, pp. -. DOI: 10.1007/s13402-026-01212-7


Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy
Author: Li, Xiaoping; Kaboli, Parham Jabbarzadeh; Roozitalab, Ghazaal; Salahi, Shanli; Qian, Hongbo; Zhang, Xinyi; Chen, Keda; Imani, Saber
Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01199-1


Role of DDX39A in modulating the tumor progression and radiosensitivity in esophageal squamous cell carcinoma
Author: Hui, Beina; Hu, Weibin; Chen, Xin; Wang, Ying; Li, Jing; Sun, Yuchen; Sun, Xuanzi; Ren, Juan
Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01206-5


Integrative analysis and functional validation identified palmitoylated PHGDH as a therapeutic target for colon adenocarcinoma
Author: Song, Yixian; Lin, Lingling; Liu, Dejian; Zhu, Mengqing; Wang, Pei; Li, Ke; Li, Aimin; Chen, Kequan; Ye, Zhanhui
Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01207-4


期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CELLULAR ONCOLOGY的语言要求,还能让CELLULAR ONCOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CELLULAR ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式IOS PRESS, NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013 BG
出版商Springer Netherlands
涉及的研究方向Biochemistry, Genetics and Molecular Biology-Cancer Research
出版国家或地区NETHERLANDS
出版语言English
出版周期Bimonthly
出版年份2011
年文章数 116点击查看年文章数趋势图
Gold OA文章占比32.50%
研究类文章占比:
文章 ÷(文章 + 综述)
78.45%
WOS期刊JCR分区
2024-2025年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:CELL BIOLOGYSCIEQ266/204
学科:ONCOLOGYSCIEQ175/328
学科:PATHOLOGYSCIEQ19/90
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:CELL BIOLOGYSCIEQ145/204
学科:ONCOLOGYSCIEQ160/328
学科:PATHOLOGYSCIEQ117/90
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 1区2区3区
ONCOLOGY
肿瘤学
2区1区3区
CELL BIOLOGY
细胞生物学
4区4区3区
PATHOLOGY
病理学
3区3区2区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 2区2区4区
ONCOLOGY
肿瘤学
4区2区2区
PATHOLOGY
病理学
1区2区2区
CELL BIOLOGY
细胞生物学
1区3区3区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区2区3区
CELL BIOLOGY
细胞生物学
1区4区2区
PATHOLOGY
病理学
4区2区2区
ONCOLOGY
肿瘤学
1区2区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-5870%5BISSN%5D
平均审稿速度网友分享经验:
16 Weeks
平均录用比例网友分享经验:
容易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CELLULAR ONCOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
期刊常用信息链接
同领域相关期刊 CELLULAR ONCOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CELLULAR ONCOLOGY期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CELLULAR ONCOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Cancer Communications040.30
    Translational Oncology417.30
    Journal of Gastric Cancer227.80
    Frontiers in Oncology606.60
    Advances in Cancer Biology Metastasis08.10
    International Journal of Medical Biochemistry00.90
    Critical Reviews in Oncogenesis02.70
    Clinical and Experimental Morphology00.70
    Molecular and Cellular Oncology03.00
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE883331
    JOURNAL OF ETHNOPHARMACOLOGY790287
    Frontiers in Immunology726517
    BIOMEDICINE & PHARMACOTHERAPY713603
    BIOMATERIALS705388
    Frontiers in Pharmacology699659
    PHYTOMEDICINE625941
    Frontiers in Oncology608456
    IEEE Journal of Biomedical and Health Informatics582387
    Biomedical Signal Processing and Control582059
  •  

    CELLULAR ONCOLOGY CELLULAR ONCOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.EBF3 suppresses lung adenocarcinoma progression and immune evasion via transcriptional repression of CCL24

    Author: Li, Lan; Yang, YiRan; Li, Dan; Chen, ChuMao; Mu, XinMei; Wu, JiaXin; Yuan, Jin
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 3, pp. -. DOI: 10.1007/s13402-026-01212-7
        PubMed      DOI
    2.Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy

    Author: Li, Xiaoping; Kaboli, Parham Jabbarzadeh; Roozitalab, Ghazaal; Salahi, Shanli; Qian, Hongbo; Zhang, Xinyi; Chen, Keda; Imani, Saber
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01199-1
        PubMed      DOI
    3.Role of DDX39A in modulating the tumor progression and radiosensitivity in esophageal squamous cell carcinoma

    Author: Hui, Beina; Hu, Weibin; Chen, Xin; Wang, Ying; Li, Jing; Sun, Yuchen; Sun, Xuanzi; Ren, Juan
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01206-5
        PubMed      DOI
    4.Integrative analysis and functional validation identified palmitoylated PHGDH as a therapeutic target for colon adenocarcinoma

    Author: Song, Yixian; Lin, Lingling; Liu, Dejian; Zhu, Mengqing; Wang, Pei; Li, Ke; Li, Aimin; Chen, Kequan; Ye, Zhanhui
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01207-4
        PubMed      DOI
    5.Transcriptional repression of TGFB2-AS1 by GATA6 drives triple-negative breast cancer metastasis

    Author: Liu, Chang; Yu, Qianru; Wang, Difei; Duan, Zheng; Zhang, Xin; Wang, Jiao; Qi, Xiaoyu; Ye, Jiayin; Zhao, Qian; He, Jianrong; Zhou, Cixiang
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01195-5
        PubMed      DOI
    6.A CREM-ITGA2B-MAPK axis drives proliferation and invasiveness in gastric cancer: insights from single-cell analysis

    Author: Wu, Hongmei; Ye, Mengnan; Zheng, Lisheng; Zhang, Yaoyao; Mei, Yan; Lu, Yi; Li, Bing; Xue, Wei; Peng, Di; Feng, Feiyan; Qiu, Yue; Sun, Jingbo; Sun, Xuegang; Bian, Xiuwu; Zhang, Qingling
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01189-3
        PubMed      DOI
    7.Lactate and lactylation: metabolic architects of tumor progression and metastasis

    Author: Ma, Hanyue; Gu, Zhuo; Wang, Zhenxin
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01182-w
        PubMed      DOI
    8.ADAMDEC1-driven CCL2-CCR2-PD-1 axis in esophageal squamous cell carcinoma: a dual threat of O-GlcNAcylation and m6A methylation in neoadjuvant therapy resistance and immune evasion

    Author: Cheng, Jiwei; Ma, Haibo; Qian, Xin; Xing, Wenqun
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01204-7
        PubMed      DOI
    9.The histone acylation network: emerging therapeutic targets for remodeling the epigenetic landscape in pancreatic ductal adenocarcinoma

    Author: Kong, Deju Anna; Wang, Huang; Wang, Mingzhen; Chen, Siyu; Cao, Dingge; Liu, Xujun; Cui, Liyan; Si, Wenzhe
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01191-9
        PubMed      DOI
    10.Targeting senescence-like tumor-associated macrophages sensitizes chemotherapy in triple-negative breast cancer

    Author: Zhou, Hongxu; Xu, Chengzhao; Zhang, Jiabeini; Liu, Yangxuzhu; Gao, Xiaochuan; He, Ziqi; Wu, Yuheng; Zhao, Qian; Liang, Baoling; Song, Dong
    Journal: CELLULAR ONCOLOGY. 2026; Vol. 49, Issue 2, pp. -. DOI: 10.1007/s13402-026-01197-3
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    NATURE REVIEWS DRUG DISCOVERY289159.20
    Kidney International Supplements24117.70
    LANCET70092.40
    Nature Reviews Clinical Oncology127126.60
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    NATURE REVIEWS CANCER39696.20
    World Psychiatry6184.80
    World Psychiatry7084.80
    ANNALS OF ONCOLOGY21069.60
    同分区等级的其他期刊名称 h-index CiteScore
    MMWR Surveillance Summaries093.20
    NEW ASTRONOMY REVIEWS5236.80
    Computational Visual Media028.60
    Journal of the National Comprehensive Cancer Network8819.40
    International Journal of Transgender Health015.10
    ENDOCRINE PATHOLOGY4222.30
    HemaSphere06.90
    IEEE Transactions on Intelligent Vehicles019.90
    BEHAVIORAL AND BRAIN SCIENCES1482.50
    CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE10226.80
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共8


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室